Arcus Bio - RCUS Net earnings per share for the last four quarters

Official company branding of Arcus Bio (RCUS)

Does the robotization of molecule screening and AI bioinformatics help optimize costs? The history of EPS YoY (ttm) percentage growth provides the answer, where the -6.20 level captures the current state. Simultaneously, Arcus Biosciences, Inc. (RCUS) is implementing eco-friendly reagent disposal and green logistics. R&D funding currently relies on partnership payments while the primary drugs undergo clinical trials.

Arcus Biosciences (RCUS) Earnings per share for the last twelve months: for the period 02/11/2024 - 11/17/2026

RCUS (Arcus Biosciences): analytical breakdowns and indicator data

Initial company analysis:RCUS, Arcus Bio
Mass-produced product of arcusbio.com

Year-over-year EPS growth (TTM) measures the trend of net income per share over a rolling year, determining the efficiency of business capitalization and its resilience to inflation. By analyzing historical year-over-year EPS growth (TTM), an investor can assess the impact of clinical trial failure risks and the dependence of Arcus Biosciences, Inc. (RCUS) on external financing on the company's actual profitability.

Direct competitors

Earnings per share for the trailing year IBRX (ImmunityBio)|IMCR: Net earnings per share (EPS TTM)|JANX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months zymeworks.com|Net earnings per share for the last 12 months tangotx.com (TNGX)|Earnings per share for the last twelve months Iovance Biotherapeutics Inc (IOVA)|Net earnings per share for the last 12 months Immatics Corp IMTX|Xencor Inc - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Compass Therapeutics Corp CMPX|REPL - Earnings per share for the last twelve months|LYEL (lyell.com) - Earnings per share for the last 12 months|Innate Pharma S.A (IPHA) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Pyxis Oncology, Inc. (PYXS)|Net earnings per share for the last 12 months CGEN|IOBT - Net earnings per share for the trailing year|Net earnings per share for the last 12 months STRO (Sutro Bio)|Earnings per share for the last four quarters INKT|Net earnings per share (EPS TTM) HOWL (Werewolf Therapeutics)|Earnings per share for the trailing year IMMX|alxoncology.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year CUE (Cue Biopharma)|PDS Biotechnology Corp (PDSB) - Earnings per share for the last twelve months|Sonnet BioTherapeutics Holdings, Inc. - Earnings per share for the trailing year|MAIA (MAIABiotech.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Liminatus Pharma Inc.|Earnings per share for the last twelve months lavatherapeutics.com (LVTX)|NXTC: Earnings per one share for the last 12 months|Leap Therapeutics - Net earnings per share for the last 12 months|Intensity Tx (INTS) - Net earnings per one share for the last twelve months|SNSE - Earnings per share for the last twelve months|Theriva Biologics - Earnings per share for the last four quarters|Gritstone Bio (GRTS) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Kineta, Inc. (KA)|Net earnings per share for the last 12 months NEXI|TSBX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) VCNX|HARP: Earnings per one share for the last 12 months